Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 08-2025 | 05-2025 | 02-2025 | 11-2024 | 08-2024 | |
| Sales | 7,894 | 44,056 | 18,453 | 13,284 | 12,588 |
| Gross Profit | 7,894 | 44,056 | 18,453 | 13,284 | 12,588 |
| Operating Expenses | 99,279 | 92,378 | 81,317 | 77,941 | 67,199 |
| Operating Income | -91,385 | -48,322 | -62,864 | -64,657 | -54,611 |
| Other Income | 4,964 | 5,618 | 6,513 | 6,116 | 5,737 |
| Pre-tax Income | -86,421 | -42,704 | -56,351 | -58,541 | -48,874 |
| Income Tax | 0 | 760 | N/A | 8 | 82 |
| Net Income Continuous | -86,421 | -43,464 | -56,351 | -58,549 | -48,956 |
| Net Income | $-86,421 | $-43,464 | $-56,351 | $-58,549 | $-48,956 |
| EPS Basic Total Ops | -1.03 | -0.52 | -0.67 | -0.74 | -0.67 |
| EPS Basic Continuous Ops | -1.03 | -0.52 | -0.67 | -0.74 | -0.67 |
| EPS Diluted Total Ops | -1.03 | -0.52 | -0.67 | -0.74 | -0.67 |
| EPS Diluted Continuous Ops | -1.03 | -0.52 | -0.67 | -0.74 | -0.67 |
| EPS Diluted Before Non-Recurring Items | -1.03 | -0.52 | -0.67 | -0.75 | -0.67 |
| EBITDA(a) | $-86,385 | $-43,225 | $-58,736 | $-71,642 | $-50,465 |